266. Familial mediterranean fever Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 28 / Drugs : 22 - (DrugBank : 5) / Drug target genes : 14 - Drug target pathways : 59
Familial mediterranean fever and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 266 | Familial mediterranean fever | - |
| 46 | Malignant rheumatoid arthritis | 14.000 |
| 56 | Behcet disease | 12.407 |
| 51 | Scleroderma | 10.468 |
| 49 | Systemic lupus erythematosus | 10.466 |
| 2 | Amyotrophic lateral sclerosis | 10.405 |
| 28 | Systemic amyloidosis | 9.036 |
| 34 | Neurofibromatosis | 8.941 |
| 65 | Primary immunodeficiency | 8.931 |
| 85 | Idiopathic interstitial pneumonia | 8.905 |
| 42 | Polyarteritis nodosa | 8.242 |
| 331 | Idiopathic multicentric castleman disease | 8.065 |
| 210 | Single Ventricle | 6.690 |
| 93 | Primary biliary cholangitis | 6.612 |
| 26 | HTLV-1-associated myelopathy | 6.547 |
| 106 | Cryopyrin-associated periodic syndrome | 4.000 |
| 50 | Dermatomyositis | 2.121 |
| 107 | Juvenile idiopathic arthritis | 2.095 |
| 84 | Sarcoidosis | 1.982 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.846 |
| 41 | Giant cell arteritis | 1.489 |
| 108 | TNF receptor-associated periodic syndrome | 1.000 |
| 267 | Hyper-IgD syndrome | 1.000 |
| 54 | Adult still disease | 1.000 |